Medulloblastoma, a common type of malignant brain cancer that accounts for 8-10% of childhood brain tumors [38], comprises four molecular subgroups (WNT, SHH, group 3, group 4) that have differing prognoses [39]. This evidence concerns the gene SHH and medulloblastoma.